4 Einträge gefunden

1. Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

   1. Weisel, Katja
   2. Martin, Thomas
   3. Krishnan, Amrita
   4. Jagannath, Sundar
   5. Londhe, Anil
   6. Nair, Sandhya
   7. Diels, Joris

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma

   1. Martin, Thomas
   2. Krishnan, Amrita
   3. Yong, Kwee
   4. Weisel, Katja
   5. Mehra, Maneesha
   6. Nair, Sandhya
   7. Qi, Keqin

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma

   1. Weisel, Katja
   2. Krishnan, Amrita
   3. Schecter, Jordan M
   4. Vogel, Martin
   5. Jackson, Carolyn C
   6. Deraedt, William
   7. Yeh, Tzu-Min

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

   1. Giralt, Sergio
   2. Garderet, Laurent
   3. Durie, Brian
   4. Cook, Gordon
   5. Gahrton, Gosta
   6. Bruno, Benedetto
   7. Hari, Paremesweran

   2015 - Forschungsinformationssystem des UKE